Preprint
Article

This version is not peer-reviewed.

Sensitive and Specific Detection of African Swine Fever Virus Variants: A Novel Quadplex Real-Time PCR Assay with Internal Control

A peer-reviewed article of this preprint also exists.

Submitted:

10 February 2025

Posted:

13 February 2025

You are already at the latest version

Abstract

African swine fever (ASF), a highly contagious and lethal viral disease, continues to devastate the global swine industry. The emergence of ASF virus (ASFV) variants with varying genomic deletions poses significant challenges to ASF control. This study presents a novel, sensitive, and reliable quadplex real-time PCR assay for detecting ASFV variants lacking key genes (I177L, EP402R, and MGF360-14L), either individually or in combination. The assay targets conserved regions within these genes, ensuring broad coverage of diverse ASFV genotypes. A porcine beta-actin (ACTB) internal control was incorporated to minimize false-negative results. Optimization and evaluation using spike-in tests demonstrated high sensitivity with a limit of detection (LOD) ranging from 1-10 plasmid copies or 0.1 TCID50 of ASFV isolates per reaction. No cross-reactivity was observed when testing serum samples from pigs infected with other common swine viruses. Further validation across a diverse panel of samples, comprising those from naturally ASFV-infected field pigs (n=54), experimentally ASFV-infected pigs (n=50), PBS-inoculated pigs (n=50), ASFV-free field pigs (n=100), and feral pigs (n=6), confirmed 100% specificity. This robust assay provides a valuable tool for rapid and accurate ASF surveillance and control efforts, facilitating the timely detection and mitigation of outbreaks caused by emerging ASFV variants.

Keywords: 
;  ;  ;  ;  ;  

1. Introduction

African swine fever (ASF) is a highly contagious and lethal viral disease affecting both domestic and wild pigs [1]. First identified in East Africa in the early 1900s, it has plagued the global swine industry for over a century [2]. Classified as a notifiable disease by the World Organization for Animal Health (WOAH), ASF has caused substantial economic losses due to pork shortages, trade restrictions, and costly eradication efforts [3,4]. While not directly harmful to humans, ASF's devastating impact on swine populations demands urgent global attention. Currently, ASF remains widespread in sub-Saharan Africa, parts of West Africa, and Sardinia, and continues to spread in Europe, Asia, the Pacific, and the Caribbean regions [4-6]. The lack of widely available vaccines and effective treatments poses a significant challenge to ASF control and eradication efforts.
African swine fever virus (ASFV), the causative agent of ASF, belonging to the genus Asfarvirus, within the Asfarviridae family [7]. It infects all members of the Suidae family, including domestic pigs, wild boars, warthogs, and bush pigs [8,9]. Clinical signs in infected pigs vary widely, ranging from highly fatal peracute infections to milder chronic forms, depending on the virulence of the virus strain and the age of the pig [10]. Highly virulent strains can cause near-100% mortality, while moderately virulent strains typically result in mortality rates between 30% and 70% [11]. The ASFV genome is large and complex, comprising a double-stranded DNA containing over 150 open reading frames (ORFs) [7,11]. Over 100 viral proteins have been identified, many with unknown functions [7,8,9,10,11,12]. ASFV has been classified into 24 genotypes (I-XXIV) based on the sequence of its major capsid protein, p72 [13]. While all 24 genotypes circulate in Africa, only genotypes I and II have been detected outside the continent [9,14]. Notably, the highly virulent strains currently affecting parts of Europe and Asia, as well as the Caribbean, belong to genotype II [4,5,9,15,16,17,18]. Furthermore, highly lethal recombinant ASFVs of genotypes I and II have been detected in Asia [19,20].
The lack of effective control tools severely hampers ASF prevention and control. Traditional vaccination approaches, including those using inactivated virus, infected cell extracts, and subunit vaccines targeting specific viral proteins, have failed to consistently induce protective immunity [21,22,23,24]. However, live-attenuated vaccines (LAVs) generated by targeted removal of virulence genes show promise. The Multigene family (MGF) and I177L are two successful targets for generating ASF LAVs. Two LAV vaccines (AVAC ASF Live and NAVET-ASFVAC) have been approved for commercial use in Vietnam. AVAC ASF Live is based on the ASFV-G-ΔMGF strain with six MGF gene deletions. NAVET-ASFVAC is based on the ASFV-G-ΔI177L strain, developed by partially deleting the I177L gene [25,26,27,28]. The EP402R gene, encoding the CD2v protein essential for hemadsorption, is often co-deleted with other virulence genes to enhance vaccine safety or serve as a DIVA marker [9,29,30,31,32,33]. The low virulent variants found in Asia in 2021 harbored deletions of MGFs and EP402R [34]. The emerging of naturally occurring non-haemadsorbing (Non-HAD) ASFV are related to EP402R gene deletion [35,36,37]. These variants are milder but highly transmissible which bring new challenges to ASF prevention and control. Effective and timely response requires not only the detection of wild-type ASFVs but also the precise identification of circulating ASFV variants, including gene deleted LAVs and naturally occurring ASFV variants.
The WOAH recommends virus isolation, fluorescent antibody (FAT) testing, real-time PCR, and conventional PCR for ASFV detection [38]. While virus isolation is the gold standard, its time-consuming nature limits its applicability for real-time disease monitoring. FAT exhibits reduced sensitivity in subacute and chronic ASF. PCR-based techniques, renowned for their sensitivity, specificity, rapidity, and versatility, are crucial for ASFV detection. It is currently the most widely used method, enabling early detection of the ASFV genome in tissues, EDTA-blood, and serum samples [39]. Multiplex PCR, similar in principle to conventional PCR, allows simultaneous detection of multiple viruses without cross-reactivity [40]. We have previously developed a multiplex real-time PCR panel for detecting 12 common swine viruses [41]. In this study, we developed a novel quadplex real-time PCR assay with an internal control. This assay aims to directly detect ASFV variants lacking the I177L, EP402R, and MGF360-14L genes, either individually or in combination, which may arise naturally or through vaccination. It will be a valuable tool for detecting and differentiating gene-deleted ASFV variants from wild-type strains.

2. Materials and Methods

2.1. Viruses and Porcine Serum Samples

ASFV VNUA-ASFV-05L1 strain (genotype II), ASFV Georgia strain (genotype II), and ASFV OURT88/1 (Genotype I), classical swine fever virus (CSFV) Alfort strain, CSFV vaccine strain C-strain are maintained in BSL-3 laboratory of Kansas State University (KSU). Porcine reproductive and respiratory syndrome virus (PRRSV) strains (VR-2332, NADC-20, JXA1-R, 1-4-4L1C), and porcine circovirus type 2 (PCV2b) are kept in Dr. Jishu Shi’s laboratory at KSU. PRV Bartha-K61 strain was kindly provided by Dr. Lynn W. Enquist (Princeton University) and is kept in Dr. Jishu Shi’s laboratory at KSU. These viruses are used for making the standards, sensitivity and specificity test for evaluation of the quadplex RT-PCR assay.
This study utilized following serum panels for evaluating the sensitivity and specificity of the quadplex RT-PCR assay,
(i)
ASFV negative pig sera: serum samples from pigs inoculated with phosphate-buffered saline (PBS, pH7.4, Thermo Scientific, Bridgewater, NJ, USA) (n=50).
(ii)
Experimentally ASFV infected pig sera: serum samples from pigs infected with the ASFV VNUA-ASFV-05L1 which confirmed ASFV positive when tested by standard ASFV RT-PCR [41] (n=50).
(iii)
Naturally ASFV-infected pig sera: serum samples from naturally ASFV infected field domestic pigs in ASFV epidemic country (The Philippines) (n=54).
(iv)
ASFV-free field domestic pig sera: serum samples from pigs in local farms in Kansas, USA (n=100).
(v)
Feral pig sera: serum samples from feral pigs caught in Kansas (collaboration with USDA APHIS Wildlife Services, Kansas Wildlife Services, USA) (n=6).
(vi)
Other common swine virus infected pig sera: serum samples from pigs infected with CSFV (n=50), PRRSV (n=50), PRV(n=10), and Bovine viral diarrhea virus (BVDV, n=4).
Panels ii, iii and serum samples from pigs infected with CSFV are maintained in BSL-3 laboratory at KSU. All other serum samples are kept in Dr. Jishu Shi’s laboratory at KSU.

2.2. Construction Databases, Sequence Analysis, and Design of Primer and Probes

All currently available sequences of ASFV I177L, EP402R, and MGF360-14L genes, and genomes containing these genes from GenBank, online ASFV sequence databases (https://asf-referencelab.info/sequence-database/ and https://asfvdb.popgenetics.net/, accessed on June 01, 2024), and other published sources are downloaded. The individual I177L, EP402R, and MGF360-14L gene sequences were combined with gene sequences derived from the ASFV whole genomes to construct the sequence databases for the I177L, EP402R, and MGF360-14L gene databases, respectively. Alignment of nucleotide sequences were performed by using the ClustalX program, version 2.1 [42]. Phylogenetic and evolutionary analyses were conducted using MEGA 11 [43]. Neighbor-joining (NJ) phylogenetic trees were generated using the p-distance Model. The robustness of the branching was evaluated by bootstrapping using 1,000 replications.
The primers and probes were designed in the most conserved region of the target gene that was identified from multiple sequence alignments to cover 100% as calculated by percentage of total sequences that matched at least one forward primer, one reverse primer and one probe sequences for each sequence. The predicted amplicon size was limited to 100–150 bp for each primer pair to potentially increase the reaction sensitivity. Primers and probes were checked for potential secondary structures and dimer formations prior to synthesis with NCBI tool Primer-Blast (https://www.ncbi.nlm.nih.gov/tools/primer-blast/index.cgi). All oligonucleotides were synthesized by Integrated DNA Technologies, Inc. (Coralville, IA, USA). The information of the primer and probe sequences, amplicon sizes, targeted genes, and numbers of available sequences used for the design for each virus are outlined in Table 1. To detect the porcine housekeeping gene, beta-actin (ACTB), we incorporated previously published primers (Forward: 5’-GACCTGACCGACTACCTCATG-3’; Reverse: 5’-TCTCCTTGATGTCCCGCAC-3’) and probe (CY5-CTACAGCTTCACCACCACGGC-BHQ2), which demonstrated excellent diagnostic performance, exhibit 100% coverage with 69 available sequences, and did not interfere with the multiplex reaction [44].

2.3. Preparation of Standard Plasmid and Optimization of Amplification Conditions

The target genes I177L, EP402R, and MGF360-14L were synthesized and cloned into pUC57 vectors by GenScript (Piscataway, NJ, USA). The plasmids were transformed into NEB® 10-beta Competent E. coli (New England Biolabs, MA, USA), purified using a Qiagen plasmid Midi Kit (Qiagen, MD, USA), and quantified with a NanoPhotometer P330 (Implen, Schatzbogen, Germany). Plasmid copy number was calculated using the formula: Plasmid copies/µL = (6.02x1023) x (ng/µL x 10-9) / (bp of plasmid x 660). Each plasmid was adjusted to a concentration of 1010 copies/µL and serially diluted tenfold with serum samples from a healthy donor pig to generate individual standard curves and determine the limit of detection (LOD).
DNA extraction was performed using an automated KingFisher™ Flex Purification System (ThermoFisher Scientific, MA, USA) with MagMAX™ Viral/Pathogen Nucleic Acid Isolation Kit (ThermoFisher Scientific, MA, USA) for 200 µL sample following the manufacturer’s instructions. Real-time PCR reactions were performed using a CFX96TMTouchTM Real-time PCR Detection System (Bio-Rad, CA, USA). Several multiplex reaction buffers, including iQTM Multiplex Powermix kit (Bio-Rad, CA, USA), QIAGEN Multiplex PCR Kit (Qiagen, MD, USA), Platinum™ Multiplex PCR Master Mix (Thermo Fisher Scientific, MA, USA), Multiplex PCR 5X Master Mix (New England Biolabs, MA, USA), and Path-ID Multiplex One-Step RT-PCR Kit (Thermo Fisher Scientific, MA, USA), were evaluated according to their respective manufacturer's instructions. Primer and probe final concentrations were set at 400 nM and 200 nM, respectively. Thermocycling parameters were adjusted according to each manufacturer's instructions. All the experiments were performed in triplicate.

2.4. Analytical Sensitivity and Specificity Evaluation by Spiking Experiments

To assess analytical sensitivity, 105 TCID50 (50% tissue culture infectious dose) of cell-cultured ASFV strains VNUA-ASFV-05L1 (genotype II), Georgia (genotype II), and OURT88/1 (genotype I) were spiked into serum samples from a healthy donor pig. These spiked samples were serially diluted tenfold. To evaluate analytical specificity, 105 TCID50 of CSFV Alfort strain, CSFV C-strain, PRRSV strains (VR-2332, NADC-20, JXA1-R, 1-4-4L1C), PCV2b, and PRV Bartha-K61 were spiked into serum samples from a healthy donor pig. Nucleic acid extraction was performed as described above. Quadplex RT-PCR was conducted using the Path-ID Multiplex One-Step RT-PCR Kit, incorporating a reverse transcription step at 48°C for 10 minutes, followed by inactivation and denaturation at 95°C for 5 minutes. Subsequent PCR cycles involved 45 cycles of denaturation at 95°C for 15 seconds and annealing/extension at 60°C for 45 seconds. All the experiments were performed in triplicate and compared with the standard singular ASFV RT-PCR [41]. Data analysis was performed using Bio-Rad CFX Maestro software (Bio-Rad, CA, USA).

2.5. Validate the Quadplex RT-PCR with Experimental and Field Samples

To validate the quadplex RT-PCR assay with experimental clinical samples, serum samples from panels i, ii, and vi were tested to evaluate its diagnostic sensitivity and specificity. To validate the quadplex RT-PCR assay with field clinical samples, serum samples from panels iii, iv, and v were tested. Nucleic acid extraction was performed as described above. Quadplex RT-PCR was conducted using the Path-ID Multiplex One-Step RT-PCR Kit, incorporating a reverse transcription step at 48°C for 10 minutes, followed by enzyme inactivation and denaturation at 95°C for 5 minutes. Subsequent PCR cycles consisted of 45 cycles of denaturation at 95°C for 15 seconds and annealing/extension at 60°C for 45 seconds. All experiments were performed in triplicate and the results were compared with those obtained using the standard singular ASFV RT-PCR [41].

2.6. Statistical Analysis

All data were obtained from three independent experiments. The significance of the correlation coefficient between the quadplex RT-PCR and the standard singular RT-PCR was determined using a t-test in SPSS Statistics for Windows, version 25.0 (IBM Corp., NY, USA). Sensitivity and specificity analyses were performed using the web-based MedCalc statistical software (https://www.medcalc.org/calc/diagnostic_test.php, accessed on January 21, 2025).

3. Results

3.1. Database for Sequence Alignment and the Design of Primers and Probes

To construct the I177L, EP402R, and MGF360-14L gene databases, we obtained 235, 263, and 236 sequences, respectively. These sequences represented p72 gene-based genotypes I, II, III, IV, V, VII, VIII, IX, X, XX, and XXII (Table 1). While the majority of sequences were from genotypes I and II, a smaller number originated from other genotypes. Genotypes VI, XI-XIX, XXI, XXIII, and XXIV were excluded due to a lack of available sequences for these genotypes in all three gene databases. Phylogenetic analysis of the I177L, EP402R, and MGF360-14L gene sequences revealed that the clades corresponding to different genotypes were consistent with those identified using the p72 gene. The genetic diversity of these three genes varied, with MGF360-14L gene exhibiting the highest level of diversity, followed by gene EP402R and I177L, as evidenced by the horizontal branch lengths in the phylogenetic tree (Figure 1).
Our novel quadplex RT-PCR assay is designed to detect I177L, EP402R, and MGF360-14L gene-deleted ASFV variants using a combination of probes and a porcine ACTB internal control (Table 2). Wild-type ASFVs will yield positive results for all probes, while gene-deleted ASFV variants will show negative results for one to three probes. This strategy enables differentiation between infections caused by wild-type and gene-deleted ASFV variants. To ensure comprehensive coverage, primers were selected from the most conserved regions of the target genes. If a single primer/probe could not cover all sequences in a given database, multiple primers/probes were chosen to achieve 100% coverage (Table 1). Primers and probes were designed within a narrow annealing temperature range and a length of 100-150 bp to optimize the compatibility and sensitivity of the multiplex reactions.

3.2. Optimization of Quadplex RT-PCR Through Standard Plasmid Spiked Experiments Using Various Multiplex Reaction Buffers

To evaluate the performance of multiplex reaction buffers for the quadplex RT-PCR assay, we serially diluted a standard plasmid containing the target gene with serum samples from a healthy donor pig. These diluted samples were then tested with five different multiplex reaction buffers. Path-ID Multiplex RT-PCR reaction buffer exhibited the optimal performance, achieving a LOD of 1-10 plasmid copies, with corresponding cycle threshold (Ct) values ranging from 35 to 38. The standard curves demonstrated high correlation coefficients (R² ≥ 0.98) and efficient PCR amplification (E = 104-105%). While the other four tested buffers also yielded acceptable results (R² ≥ 0.94, E ≥ 80%), their LOD was slightly lower (10-100 plasmid copies) (Table 3). Based on these findings, Path-ID Multiplex One-Step RT-PCR reaction buffer was selected for our quadplex RT-PCR system. Consistent with previous findings [44], the amplification of internal control ACTB gene did not exhibit interference with target gene amplification. Its Ct values remained stable around 28 in all tested samples, and it did not influence the standard curves.

3.3. Analytical Sensitivity and Specificity of Quadplex RT-PCR in Virus Spiked Samples

Quadplex RT-PCR demonstrated excellent sensitivity when applied to ASFVs-spiked pig serum samples. The LOD was determined to be 0.1 TCID50 for both Genotype I and Genotype II viruses across all three target genes, aligning with the performance of standard singular RT-PCR assay (Table 4). The strong correlation between quadplex RT-PCR and standard singular RT-PCR, with correlation coefficients ranging from 0.97 to 0.99, further supports the sensitivity of the quadplex RT-PCR assay. The internal control ACTB gene consistently amplified with Ct values around 28, indicating no interference with target gene amplification in all tested samples.
To evaluate specificity, the quadplex RT-PCR was applied to pig serum samples spiked with high quantities (105 TCID50) of other common swine viruses, including CSFV, PRRSV, PCV, and PRV (Table 4). No cross-reactivity was observed, confirming the specificity of the assay.

3.4. Diagnostic Sensitivity and Specificity of Quadplex RT-PCR in Clinical Samples from Experimental Infected Pigs

To further evaluate the quadplex RT-PCR assay, we used serum samples collected from ten pigs infected with ASFV VNUA-ASFV-05L1 (genotype II) from 7 DPI (days post infection) to the day they were euthanized (between 8 and 16 DPI). This virus was isolate from a domestic pig during an ASF outbreak in Northern Vietnam in 2020 and caused typical clinical signs of acute ASF [45]. All 50 samples which tested positive by standard singular ASFV RT-PCR are positive for the targets included in quadplex RT-PCR (Table 5). Quadplex RT-PCR showed similar Ct values ranging from 19 to 40 with the standard singular ASFV RT-PCR.
We further tested our quadplex RT-PCR with various serums samples categories from other common swine virus experimentally infected pigs. The results are encouraging (Table 5). The quadplex RT-PCR did not show any false positive, meaning it has 100% specificity for detecting ASFV in these samples.

3.5. Performance of Quadplex RT-PCR on Field Clinical Samples

To evaluate the performance of the quadplex RT-PCR with field samples, we analyzed sera from three sources: 1) naturally ASFV-infected domestic pigs in the Philippines (an ASFV-endemic country), 2) domestic pigs from local farms in Kansas, and 3) feral pigs captured in Kansas. The quadplex RT-PCR demonstrated ideal results, yielding negative results for all ASFV-free field samples from domestic pigs in Kansas (n=100). All positive samples from ASFV-infected pigs in the Philippines, previously identified as positive by the standard singular ASFV RT-PCR [41], also tested positive with our quadplex RT-PCR, confirming 100% specificity. Moreover, serum samples from feral pigs (n=6) were all negative using the quadplex RT-PCR, further supporting 100% specificity when compared to the standard singular ASFV RT-PCR (Table 6).

4. Discussion

ASF remains a significant global threat due to the complex nature of the virus, the lack of a widely available effective vaccine, and persistent knowledge gaps despite recent research progress [4]. Currently, ASF control still primarily relied on early detection and robust biosecurity measures. However, the emergence of gene-deleted, low-virulence ASFV variants, often exhibiting milder disease and reduced mortality, presents new challenges for diagnosis and control [34-37]. Therefore, developing rapid, sensitive, and accurate diagnostic methods for detecting circulating ASFVs, including wild-type ASFVs, gene deleted LAVs, and naturally occurring ASFV variants, is crucial for implementing timely and targeted interventions to prevent further spread and mitigate their impact on pig populations.
Real-time PCR is a rapid and sensitive method for detecting ASFV DNA in clinical samples. Numerous highly sensitive and specific real-time PCR assays have been developed and validated for ASFV diagnosis worldwide [46,47]. In addition, multiplex real-time PCR has been employed to improve efficiency by detecting multiple targets simultaneously. For example, multiplex real-time PCRs to distinguish ASFV genotypes I and II [48] and to simultaneous detect multiple swine viruses [41, 49]. These PCR assays, while efficient, generally cannot differentiate between ASFV variants and wild-type strains. This study presents a novel, sensitive, and specific quadplex real-time PCR assay for the direct detection of ASFV variants lacking the I177L, EP402R, and MGF360-14L genes, either individually or in combination. This assay significantly improves detection efficiency by simultaneously screening for multiple variants, and has the ability to differentiate I177L, EP402R, and MGF360-14L gene deleted ASFV variants and wild-type ASFVs (Table 2).
The assay exhibited remarkable specificity (100%), ensuring exclusive amplification and detection of the targeted ASFV viral nucleic acids. High sensitivity, with a limit of detection (LOD) ranging from 1-10 plasmid copies or 0.1 TCID50 of ASFV isolates (for both Genotype I and II) per reaction for all three genes, enabled the detection of even low viral loads, crucial for early-stage infection diagnosis. Standard curves demonstrated high correlation coefficients (R² ≥ 0.98) and efficient PCR amplification (E = 104-105%). The porcine ACTB gene, a housekeeping gene present in most sample types, served as an internal control, eliminating the need for additional preparation or inoculation steps [44]. Consistent amplification of the porcine ACTB internal control with Ct values around 28 across all pig samples indicated effective monitoring of extraction efficiencies, no interference with target gene amplification, and robust diagnostic performance.
The developed quadplex RT-PCR assay was employed to analyze both experimental and field clinical samples. Compared to the standard singular ASFV RT-PCR, it exhibited excellent sensitivity. All samples that tested positive with the standard singular assay also yielded positive results for the targets included in the quadplex assay. Moreover, quadplex RT-PCR demonstrated comparable Ct values (ranging from 19 to 40) to the standard assay (Table 5). Importantly, the quadplex assay showed 100% specificity across naturally ASFV-infected and ASFV-free field samples, including those from feral pigs, indicating robust field diagnostic performance. These results underscore the potential of this assay as a valuable field-deployable tool for identifying and monitoring ASFV variants in wild pig populations. Further field validation studies are planned to expand sample types, assess sample quality under diverse environmental conditions, and solidify these promising findings. We will report the findings soon.

5. Conclusions

This study successfully developed a sensitive and accurate quadplex RT-PCR assay with an internal control for the detection and differentiation of ASFV variants harboring deletions in the I177L, EP402R, and MGF360-14L genes from wild-type ASFV strains. This robust assay, characterized by high sensitivity and specificity, demonstrates significant potential for the effective detection and investigation of ASFV variants in field clinical samples.

Author Contributions

Conceptualization, L.W. and J.S.; methodology, L.W., Y.L., and X.Z.; formal analysis, L.W., Y.L., X.Z. and J.S.; investigation, L.W., Y.L., X.Z, R.M., H.P., A.C., N.M., D.L., J.R., F.M.F., Q.L.T., and L.T.N.; resources, L.W. and J.S.; writing—original draft preparation, L.W.; writing —review and editing, L.W. and J.S; supervision, L.W. and J.S.; funding acquisition, L.W. and J.S. All authors have read and agreed to the published version of the manuscript.

Funding

This work is supported by the [Development and validation of novel diagnostic tools for rapid and early detection of emerging infection from ASFV variants], project award no. [2022-67015-36516], from the U.S. Department of Agriculture’s National Institute of Food and Agriculture; the National Bio and Agro-Defense Facility Transition Fund, the USDA National Institute of Food and Agriculture, Hatch-Multistate project (grant number: 1021491); the USDA ARS Non-Assistance Cooperative Agreements (grant numbers: 58-8064-8-011, 58-8064-9-007, 58-3020-9-020; the USDA NIFA Subaward #25-6226-0633-002; and the Department of Homeland Security (grant number: 70RSAT19CB0000027).

Institutional Review Board Statement

The study was conducted according to the guidelines and approved protocols by Institutional Animal Care and Use Committee (IACUC) at Kansas State University (IACUC#4673).

Informed Consent Statement

Not Applicable.

Data Availability Statement

All data pertinent to the study are included in the article.

Acknowledgments

We thank the dedicated staff of the Comparative Medicine department and the Biosecurity Research Institute at Kansas State University for their exceptional technical support.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Dixon, L.K.; Stahl, K.; Jori, F.; Vial, L.; Pfeiffer, D.U. African swine fever epidemiology and control. Annu. Rev. Anim. Biosci. 2020, 8, 221–246. [Google Scholar] [CrossRef]
  2. Montgomery, R.E. On a form of swine fever occurring in British East Africa (Kenya Colony). J. Comp. Pathol. Ther. 1921, 34, 159–191. [Google Scholar] [CrossRef]
  3. Li, Z.; Chen, W.; Qiu, Z.; Li, Y.; Fan, J.; Wu, K.; Li, X.; Zhao, M.; Ding, H.; Fan, S.; Chen, J. African Swine Fever Virus: A Review. Life (Basel) 2024, 14(3), 381. [Google Scholar] [CrossRef]
  4. Wang, L.; Ganges, L.; Dixon, L.K.; Bu, Z.; Zhao, D.; Truong, Q.L.; Richt, J.A.; Jin, M.; Netherton, C.L.; Benarafa, C.; Summerfield, A.; Weng, C.; Peng, G.; Reis, A.L.; Han, J.; Penrith, M. L.; Mo, Y.; Su, Z.; Vu Hoang, D.; Pogranichniy, R.M.; Balaban-Oglan, D.A.; Li, Y.; Wang, K.; Cai, X.; Shi, J. International African Swine Fever Workshop: Critical Issues That Need to Be Addressed for ASF Control. Viruses 2023, 16(1), 4. [Google Scholar] [CrossRef] [PubMed]
  5. Shi, J.; Wang, L.; McVey, D.S. Of pigs and men: The best-laid plans for prevention and control of swine fevers. Anim. Front. 2021, 11, 6–13. [Google Scholar] [CrossRef] [PubMed]
  6. Ruedas-Torres, I.; Thi To Nga, B.; Salguero, F.J. Pathogenicity and virulence of African swine fever virus. Virulence 2024, 15, 2375550. [Google Scholar] [CrossRef]
  7. Karger, A.; Pérez-Núñez, D.; Urquiza, J.; Hinojar, P.; Alonso, C.; Freitas, F. B.; Revilla, Y.; Le Potier, M. F.; Montoya, M. An Update on African Swine Fever Virology. Viruses 2019, 11(9), 864. [Google Scholar] [CrossRef]
  8. Sánchez-Vizcaíno, J.M.; Mur, L.; Martínez-López, B. African swine fever: an epidemiological update. Transbound. Emerg. Dis. 2012, 59 Suppl 1, 27–35. [Google Scholar] [CrossRef]
  9. Vu, H.L.X.; McVey, D.S. Recent progress on gene-deleted live-attenuated African swine fever virus vaccines. NPJ Vaccines. 2024, 9(1), 60. [Google Scholar] [CrossRef]
  10. Post, J.; Weesendorp, E.; Montoya, M.; Loeffen, W.L. Influence of Age and Dose of African Swine Fever Virus Infections on Clinical Outcome and Blood Parameters in Pigs. Viral Immunol. 2017, 30(1), 58–69. [Google Scholar] [CrossRef]
  11. Dixon, L.K.; Sun, H.; Roberts, H. African swine fever. Antiviral Res. 2019, 165, 34–41. [Google Scholar] [CrossRef]
  12. Alejo, A.; Matamoros, T.; Guerra, M.; Andrés, G. A Proteomic Atlas of the African Swine Fever Virus Particle. J. Virol. 2018, 92(23), e01293–18. [Google Scholar] [CrossRef]
  13. Quembo, C. J.; Jori, F.; Vosloo, W.; Heath, L. Genetic characterization of African swine fever virus isolates from soft ticks at the wildlife/domestic interface in Mozambique and identification of a novel genotype. Transbound Emerg. Dis. 2018, 65(2), 420–431. [Google Scholar] [CrossRef] [PubMed]
  14. Arias, M.; de la Torre, A.; Dixon, L.; Gallardo, C.; Jori, F.; Laddomada, A.; Martins, C.; Parkhouse, R.M.; Revilla, Y.; Rodriguez, F.A.J.; Sanchez-Vizcaino. Approaches and Perspectives for Development of African Swine Fever Virus Vaccines. Vaccines (Basel) 2017, 5(4), 35. [Google Scholar] [CrossRef] [PubMed]
  15. Sánchez-Vizcaíno, J. M.; Mur, L.; Martínez-López, B. African swine fever (ASF): five years around Europe. Vet. Microbiol. 2013, 165(1-2), 45–50. [CrossRef]
  16. Ge, S.; Li, J.; Fan, X.; Liu, F.; Li, L.; Wang, Q.; Ren, W; Bao, J; Liu, C; Wang, H; Liu, Y.; Zhang, Y.; Xu, T.; Wu, X.; Wang, Z. Molecular characterization of African swine fever virus, China, 2018. Emerg. Infect. Dis. 2018, 24(11), 2131–2133. [CrossRef]
  17. Cwynar, P.; Stojkov, J.; Wlazlak, K. African swine fever status in Europe. Viruses 2019, 11(4), 310. [Google Scholar] [CrossRef]
  18. Ruiz-Saenz, J.; Diaz, A.; Bonilla-Aldana, D. K.; Rodríguez-Morales, A. J.; Martinez-Gutierrez, M.; Aguilar, P. V. African swine fever virus: A re-emerging threat to the swine industry and food security in the Americas. Front. Microbiol. 2022, 13, 1011891. [Google Scholar] [CrossRef] [PubMed]
  19. Zhao, D.; Sun, E.; Huang, L.; Ding, L.; Zhu, Y.; Zhang, J.; Shen, D.; Zhang, X.; Zhang, Z.; Ren, T.; Wang, W.; Li, F.; He, X.; Bu, Z. Highly lethal genotype I and II recombinant African swine fever viruses detected in pigs. Nat. Commun. 2023, 14(1), 3096. [Google Scholar] [CrossRef]
  20. Le, V.P.; Nguyen, V.T.; Le, T.B.; Mai, N.T.A.; Nguyen, V.D.; Than, T.T.; Lai, T.N.H.; Cho, K.H.; Hong, S.K.; Kim, Y.H.; Bui, T.A.D.; Nguyen, T.L.; Song, D.; Ambagala, A. Detection of Recombinant African Swine Fever Virus Strains of p72 Genotypes I and II in Domestic Pigs, Vietnam, 2023. Emerg. Infect. Dis. 2024, 30(5), 991–994. [Google Scholar] [CrossRef]
  21. Escribano, J.M.; Galindo, I.; Alonso, C. Antibody-mediated neutralization of African swine fever virus: myths and facts. Virus Res. 2013, 173(1), 101–109. [Google Scholar] [CrossRef]
  22. Pikalo, J.; Porfiri, L.; Akimkin, V.; Roszyk, H.; Pannhorst, K.; Kangethe, R.T.; Wijewardana, V.; Sehl-Ewert, J.; Beer, M.; Cattoli, G.; Blome, S. Vaccination with a Gamma Irradiation-Inactivated African Swine Fever Virus Is Safe but Does Not Protect Against a Challenge. Front Immunol. 2022, 13, 832264. [Google Scholar] [CrossRef]
  23. Rock, D.L. Thoughts on African Swine Fever Vaccines. Viruses 2021, 13(5), 943. [Google Scholar] [CrossRef] [PubMed]
  24. Gaudreault, N.N.; Richt, J.A. Subunit Vaccine Approaches for African Swine Fever Virus. Vaccines (Basel) 2019, 7(2), 56. [Google Scholar] [CrossRef]
  25. O'Donnell, V.; Holinka, L.G.; Gladue, D.P.; Sanford, B.; Krug, P.W.; Lu, X.; Arzt, J.; Reese, B.; Carrillo, C.; Risatti, G.R.; Borca, M.V. African Swine Fever Virus Georgia Isolate Harboring Deletions of MGF360 and MGF505 Genes Is Attenuated in Swine and Confers Protection against Challenge with Virulent Parental Virus. J Virol. 2015, 89(11), 6048–56. [Google Scholar] [CrossRef] [PubMed]
  26. Borca, M.V.; Ramirez-Medina, E.; Silva, E.; Vuono, E.; Rai, A.; Pruitt, S.; Holinka, L.G.; Velazquez-Salinas, L.; Zhu, J.; Gladue, D.P. Development of a Highly Effective African Swine Fever Virus Vaccine by Deletion of the I177L Gene Results in Sterile Immunity against the Current Epidemic Eurasia Strain. J Virol. 2020, 94(7), e02017–19. [Google Scholar] [CrossRef]
  27. Tran, X.H.; Le, T.T.P.; Nguyen, Q.H.; Do, T.T.; Nguyen, V.D.; Gay, C.G.; Borca, M.V.; Gladue, D.P. African swine fever virus vaccine candidate ASFV-G-ΔI177L efficiently protects European and native pig breeds against circulating Vietnamese field strain. Transbound Emerg Dis. 2022, 69(4), e497–e504. [Google Scholar] [CrossRef]
  28. Borca, M.V.; Rai, A.; Ramirez-Medina, E.; Silva, E.; Velazquez-Salinas, L.; Vuono, E.; Pruitt, S.; Espinoza, N.; Gladue, D.P. A Cell Culture-Adapted Vaccine Virus against the Current African Swine Fever Virus Pandemic Strain. J Virol. 2021, 95(14), e0012321. [Google Scholar] [CrossRef]
  29. Xie, Z.; Liu, Y.; Di, D.; Liu, J.; Gong, L.; Chen, Z.; Li, Y.; Yu, W.; Lv, L.; Zhong, Q.; Song, Y.; Liao, X.; Song, Q.; Wang, H.; Chen, H. Protection Evaluation of a Five-Gene-Deleted African Swine Fever Virus Vaccine Candidate Against Homologous Challenge. Front Microbiol. 2022, 13, 902932. [Google Scholar] [CrossRef] [PubMed]
  30. Petrovan, V.; Rathakrishnan, A.; Islam, M.; Goatley, L.C.; Moffat, K.; Sanchez-Cordon, P.J.; Reis, A.L.; Dixon, L.K. Role of African Swine Fever Virus Proteins EP153R and EP402R in Reducing Viral Persistence in Blood and Virulence in Pigs Infected with BeninΔDP148R. J Virol. 2022, 96(1), e0134021. [Google Scholar] [CrossRef]
  31. Teklue, T.; Wang, T.; Luo, Y.; Hu, R.; Sun, Y.; Qiu, H.J. Generation and Evaluation of an African Swine Fever Virus Mutant with Deletion of the CD2v and UK Genes. Vaccines (Basel) 2020, 8(4), 763. [Google Scholar] [CrossRef]
  32. Chen, W.; Zhao, D.; He, X.; Liu, R.; Wang, Z.; Zhang, X.; Li, F.; Shan, D.; Chen, H.; Zhang, J.; Wang, L.; Wen, Z.; Wang, X.; Guan, Y.; Liu, J.; Bu, Z. A seven-gene-deleted African swine fever virus is safe and effective as a live attenuated vaccine in pigs. Sci. China Life Sci. 2020, 63(5), 623–634. [Google Scholar] [CrossRef]
  33. Wang, L.; Fu, D.; Tesfagaber, W.; Li, F.; Chen, W.; Zhu, Y.; Sun, E.; Wang, W.; He, X.; Guo, Y.; Bu, Z.; Zhao, D. Development of an ELISA Method to Differentiate Animals Infected with Wild-Type African Swine Fever Viruses and Attenuated HLJ/18-7GD Vaccine Candidate. Viruses 2022, 14(8), 1731. [Google Scholar] [CrossRef]
  34. Sun, E.; Huang, L.; Zhang, X.; Zhang, J.; Shen, D.; Zhang, Z.; Wang, Z.; Huo, H.; Wang, W.; Huangfu, H.; Wang, W.; Li, F.; Liu, R.; Sun, J.; Tian, Z.; Xia, W.; Guan, Y.; He, X.; Zhu, Y.; Zhao, D.; Bu, Z. Genotype I African swine fever viruses emerged in domestic pigs in China and caused chronic infection. Emerg. Microbes Infect. 2021, 10(1), 2183–2193. [Google Scholar] [CrossRef] [PubMed]
  35. Leitão, A.; Cartaxeiro, C.; Coelho, R.; Cruz, B.; Parkhouse, R.M.E.; Portugal, F.C.; Vigário, J.D.; Martins, C.L.V. The non-haemadsorbing African swine fever virus isolate ASFV/NH/P68 provides a model for defining the protective anti-virus immune response. J. Gen. Virol. 2001, 82(Pt 3), 513–523. [Google Scholar] [CrossRef]
  36. Gallardo, C.; Soler, A.; Rodze, I.; Nieto, R.; Cano-Gómez, C.; Fernandez-Pinero, J.; Arias, M. Attenuated and non-haemadsorbing (non-HAD) genotype II African swine fever virus (ASFV) isolated in Europe, Latvia 2017. Transbound Emerg. Dis. 2019, 66(3), 1399–1404. [Google Scholar] [CrossRef] [PubMed]
  37. Boinas, F.S.; Hutchings, G.H.; Dixon, L.K.; Wilkinson, P. J. Characterization of pathogenic and non-pathogenic African swine fever virus isolates from Ornithodoros erraticus inhabiting pig premises in Portugal. J. Gen. Virol. 2004, 85(Pt 8), 2177–2187. [Google Scholar] [CrossRef]
  38. World Organisation for Animal Health. Available at: https://www.Woah.Org/En/What-We-Do/Standards/Codes-and-Manuals/Terrestrial-Manual-Online-Access/ (Accessed January 25, 2025).
  39. Oura, C.A.; Edwards, L.; Batten, C.A. Virological diagnosis of African swine fever--comparative study of available tests. Virus Res. 2013, 173(1), 150–158. [Google Scholar] [CrossRef]
  40. Hu, L.; Lin, X.Y.; Yang, Z.X.; Yao, X.P.; Li, G.L.; Peng, S.Z.; Wang, Y. A multiplex PCR for simultaneous detection of classical swine fever virus, African swine fever virus, highly pathogenic porcine reproductive and respiratory syndrome virus, porcine reproductive and respiratory syndrome virus and pseudorabies in swine. Pol. J. Vet. Sci. 2015, 18(4), 715–23. [Google Scholar] [CrossRef]
  41. Shi, X.; Liu, X.; Wang, Q.; Das, A.; Ma, G.; Xu, L.; Sun, Q.; Peddireddi, L.; Jia, W.; Liu, Y.; Anderson, G.; Bai, J.; Shi, J. A multiplex real-time PCR panel assay for simultaneous detection and differentiation of 12 common swine viruses. J. Virol. Methods 2016, 236, 258–265. [Google Scholar] [CrossRef] [PubMed]
  42. Thompson, J.D.; Gibson, T.J.; Plewniak, F.; Jeanmougin, F.; Higgins, D.G. CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res. 1997, 25(24), 4876–82. [Google Scholar] [CrossRef]
  43. Tamura, K.; Stecher, G.; Kumar, S. MEGA11: Molecular Evolutionary Genetics Analysis Version 11. Mol Biol Evol. 2021, 38(7), 3022–3027. [Google Scholar] [CrossRef]
  44. Wang, Y.; Xu, L.; Noll, L.; Stoy, C.; Porter, E.; Fu, J.; Feng, Y.; Peddireddi, L.; Liu, X.; Dodd, K.A.; Jia, W.; Bai, J. Development of a real-time PCR assay for detection of African swine fever virus with an endogenous internal control. Transbound Emerg Dis. 2020, 67(6), 2446–2454. [Google Scholar] [CrossRef] [PubMed]
  45. Truong, Q. L.; Nguyen, T. L.; Nguyen, T. H.; Shi, J.; Vu, H. L. X.; Lai, T. L. H.; Nguyen, V. G. Genome Sequence of a Virulent African Swine Fever Virus Isolated in 2020 from a Domestic Pig in Northern Vietnam. Microbiol Resour Announc. 2021, 10(19), e00193–21. [Google Scholar] [CrossRef]
  46. Hu, Z.; Tian, X.; Lai, R.; Wang, X.; Li, X. Current detection methods of African swine fever virus. Front Vet Sci. 2023, 10, 1289676. [Google Scholar] [CrossRef] [PubMed]
  47. Zhu, Y.; Zhang, M.; Jie, Z.; Guo, S.; Zhu, Z.; Tao, S.C. Strategic nucleic acid detection approaches for diagnosing African swine fever (ASF): navigating disease dynamics. Vet Res. 2024, 55(1), 131. [Google Scholar] [CrossRef] [PubMed]
  48. Qian, X.; Hu, L.; Shi, K.; Wei, H.; Shi, Y.; Hu, X.; Zhou, Q.; Feng, S.; Long, F.; Mo, S.; Li, Z. Development of a triplex real-time quantitative PCR for detection and differentiation of genotypes I and II African swine fever virus. Front Vet Sci. 2023, 10, 1278714. [Google Scholar] [CrossRef]
  49. Chen, Y.; Shi, K.; Liu, H.; Yin, Y.; Zhao, J.; Long, F.; Lu, W.; Si, H. Development of a multiplex qRT-PCR assay for detection of African swine fever virus, classical swine fever virus and porcine reproductive and respiratory syndrome virus. J. Vet. Sci. 2021, 22(6), e87. [Google Scholar] [CrossRef]
Figure 1. Phylogenetic analysis of sequences from I177L, EP402R, and MGF360-14L databases. The Neighbor-Joining trees were constructed using MEGA11 [43]. Bootstrap support values (1000 replicates) are shown above branches. The genetic distances were calculated using the p-distance method. Horizontal branch lengths are proportional to genetic distance and vertical branch lengths have no significance. Sequences are identified by using GenBank number. The numbers I to XXII indicate genotypes I to XXII.
Figure 1. Phylogenetic analysis of sequences from I177L, EP402R, and MGF360-14L databases. The Neighbor-Joining trees were constructed using MEGA11 [43]. Bootstrap support values (1000 replicates) are shown above branches. The genetic distances were calculated using the p-distance method. Horizontal branch lengths are proportional to genetic distance and vertical branch lengths have no significance. Sequences are identified by using GenBank number. The numbers I to XXII indicate genotypes I to XXII.
Preprints 148926 g001
Table 1. Primer and probe sequences with corresponding coverages for amplifying target genes in the I177L, EP402R, and MGF360-14L gene databases.
Table 1. Primer and probe sequences with corresponding coverages for amplifying target genes in the I177L, EP402R, and MGF360-14L gene databases.
Target Gene (product size) Primer/Probe Sequence (5'-3') Genotypes/sequence numbers (n=) and coverages (%) Total
I II III IV V VII VIII IX X XX XXII
I177L (147 bp) n=103 n=106 n=1 n=2 n=1 n=3 n=2 n=6 n=5 n=5 n=1 n=235
Forward1 TGTACTGGAAAAAACTTTATCGG 100% 100% 1%
Forward2 TGAACTGGAAAAAACTTTAACGG 100% 100% 100% 100% 100% 100% 100% 94%
Forward3 TGAACTGATATAAATCCTTAACGG 100% 100% 5%
Reverse1 AATGTGGAAAGATAATGAACAGG 100% 100% 1%
Reverse2 AATGTGGAAAGTTAATGATCAGG 100% 100% 100% 100% 100% 100% 100% 100% 96%
Reverse3 AATGTGGAAAATTGATGATAAGG 100% 3%
Probe GAAGGGGGATCCGTATAAAATCCTAGCTTG 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100%
EP402R (145 bp) n=108 n=129 n=1 n=2 n=1 n=3 n=2 n=6 n=5 n=5 n=1 n=263
Forward1 ACATGTTGAAGAAATAGAAAGTC 100% 100% 100% 50% 100% 100% 100% 100% 100% 60% 98%
Forward2 CATGTTGCAGAAATACAAAGTCC 50% 40% 100% 2%
Reverse1 AGGTGTATTATATTGATAACGACT 60% 60% 2%
Reverse2 AGGTGTATTATACTGATAACGACT 100% 100% 100% 100% 100% 100% 100% 100% 40% 40% 100% 98%
Probe TCTCCCAGAGAACCATTACTTCCTAAGCC 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100%
MGF
360-14L (101 bp)
n=102 n=105 n=1 n=2 n=1 n=3 n=5 n=6 n=5 n=5 n=1 n=236
Forward1 AGAAGACGGGGTTCGGATACAG 100% 100% 100% 100% 100% 100% 100% 100% 93%
Forward2 AGAAGACGAGATTCGGAGACAG 100% 100% 100% 7%
Reverse1 GCAAATCCTGAATATGGGCTTATACG 100% 100% 100% 80% 40% 100% 100%
Reverse2 GCAAATCCTGAATATGGACTTATACG 100% 100% 100% 20% 100% 100% 60%
Probe1 CCTCCCAGTTCCGCACACAGCCG 100% 100% 100% 100% 100% 100% 100% 100% 100%
Probe2 CCTCCTAGTTCCGTGCACAGCCG 100% 100% 100%
Note: “n”, sequence number of each genotype/total number of all genotypes; “%”, percentage coverage of each primer/probe sequence within the corresponding genotype.
Table 2. Strategy for novel quadplex RT-PCR assay to detect ASFV variants.
Table 2. Strategy for novel quadplex RT-PCR assay to detect ASFV variants.
Viruses Probes with different dyes
VIC labeled EP402R probe FAM labeled
I177L probe
Texas Red labeled MGF360-14L probe Cy5 labeled ACTB probe
Wild-type ASFVs + + + +
ASFVΔEP402R - + + +
ASFVΔI177L + - + +
ASFVΔMGF360-14L + + - +
Note: EP402R probe was labelled with 5’-VIC and 3’-BHQ1; I177L probe was labelled with 5’-FAM and 3’-BHQ1; MGF360-14L probe was labelled with 5’-Texas Red and 3’-BHQ2; ACTB probe was labelled with 5’-Cy5 and 3’-BHQ2; “+”, positive; “-”, negative.
Table 3. Analytical sensitivity of quadplex RT-PCR with different multiplex reaction buffers using plasmid spiked samples.
Table 3. Analytical sensitivity of quadplex RT-PCR with different multiplex reaction buffers using plasmid spiked samples.
Target Quadplex RT-PCR with different reaction buffer
B1 B2 B3 B4 B5
I177L R2 0.99 0.96 0.96 0.94 0.97
E 105% 109% 91% 100% 95%
LOD 1 100 100 10 100
EP402R R2 0.99 0.96 0.94 0.98 0.98
E 105% 102% 89% 90% 81%
LOD 10 10 100 100 100
MGF360-14L R2 0.98 0.98 0.98 0.99 0.96
E 104% 108% 80% 101% 92%
LOD 1 10 10 10 10
Note: “R2”, Correlation coefficient; “E”, PCR amplification efficiency; “LOD”, Limit of detection (Copies/reaction from 200 µL samples); “B1”, Path-ID Multiplex RT-PCR reaction buffer; “B2-B5”, other four multiplex reaction buffer tested in this study. The presented data is the average value calculated from three independent experiments.
Table 4. Sensitivity and specificity test of quadplex RT-PCR and singular RT-PCRs with virus spiked pig serum samples.
Table 4. Sensitivity and specificity test of quadplex RT-PCR and singular RT-PCRs with virus spiked pig serum samples.
Viruses Quantity (TCID50) spiked Quadplex RT-PCR Standard singular
RT-PCR
Sensitivity Specificity Sensitivity Specificity
ASFV OURT88/1 (GI) Ten-fold
serial dilution
from 105
LOD=0.1 + LOD=0.1 +
VNUA-ASFV-05L1 (GII) LOD=0.1 + LOD=0.1 +
Georgia strain (GII) LOD=0.1 + LOD=0.1 +
CSFV Alfort strain 105 UD - UD -
C-strain UD - UD -
PRRSV VR-2332 105 UD - UD -
NADC-20 UD - UD -
JXA1-R UD - UD -
1-4-4L1C UD - UD -
PCV PCV2b 105 UD - UD -
PRV Bartha-K61 105 UD - UD -
Note: “LOD”, limit of detection; “UD”, underdetermined; “,” negative; “+,” positive. LODs for all three genes in quadplex RT-PCR are 0.1 TCID50. The standard singular ASFV RT-PCR was performed as previously described [41]. The data presented were derived from three independent experiments.
Table 5. Evaluation of quadplex RT-PCR sensitivity and specificity compared to standard singular RT-PCR assays in serum samples from experimentally infected pigs.
Table 5. Evaluation of quadplex RT-PCR sensitivity and specificity compared to standard singular RT-PCR assays in serum samples from experimentally infected pigs.
Pig serum samples Number of samples Standard singular ASFV RT-PCR Quadplex RT-PCR Positive Negative Specificity
I177L EP402R MGF ACTB
ASFV infected 50 +
(Ct 19-40)
+
(Ct 19-40)
+
(Ct 19-40)
+
(Ct 19-40)
+
(Ct 28)
50/50 0/50 100%
PBS injected 50 - - - - + 0/50 50/50 100%
CSFV-infected 50 - - - - + 0/50 50/50 100%
PRRSV-infected 50 - - - - + 0/50 50/50 100%
PRV-infected 10 - - - - + 0/10 10/10 100%
BVDV-infected 4 - - - - + 0/4 4/4 100%
Note: “−,” negative; “+,” positive. The standard singular ASFV RT-PCR was performed as previously described [41]. The data presented were derived from three independent experiments.
Table 6. Validation of the quadplex RT-PCR with field samples.
Table 6. Validation of the quadplex RT-PCR with field samples.
Samples Number of samples Standard singular ASFV RT-PCR Quadplex RT-PCR Positive Negative Specificity
I177L EP402R MGF ACTB
Naturally ASFV-infected pig sera 54 + + + + + 54/54 0/54 100%
ASFV free pig sera 100 - - - - + 0/100 100/100 100%
Feral pig sera 6 - - - - + 0/6 6/6 100%
Note: “−,” negative; “+,” positive. The standard singular ASFV RT-PCR was performed as previously described [41]. The data presented were derived from three independent experiments.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.
Prerpints.org logo

Preprints.org is a free preprint server supported by MDPI in Basel, Switzerland.

Subscribe

Disclaimer

Terms of Use

Privacy Policy

Privacy Settings

© 2025 MDPI (Basel, Switzerland) unless otherwise stated